English

CYTOKINETICS INC

EDGAR

CYTK Quarterly report (10-Q) · filed 2026-08-06

Annual consolidated revenue for 2025: about USD 88.04M, using the latest reported figures. The previous period, 2024, was about USD 18.47M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

28.6 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 28624000 USD Source

Operating margin

-625.95%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -179172000 USD Source
Revenue: 28624000 USD Source

Operating cash flow

-160 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -305300000 USD Source
Operating Cash Flow: -145500000 USD Source

Free cash flow

-164 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -305300000 USD Source
Operating Cash Flow: -145500000 USD Source
Capital Expenditure: 10264000 USD Source
Capital Expenditure: 5930000 USD Source

Cash and cash equivalents: 255 million USD 2026-06-30 Source
Exact value

255271000 USD
Long-term debt including current maturities: 1 billion USD 2025-09-30 Source
Exact value

1001919000 USD
Shares outstanding: 123 million shares 2025-12-31 Source
Exact value

122943172 shares

Reported share-count change

4.00% · 4.73 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

118209139 shares · 2024-12-31· Source
122943172 shares · 2025-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

67.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 1936000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 88039000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 70284000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 19355000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 28624000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-894 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -306178000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -785000000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -601900000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -206031000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -198762000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-555 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -367400000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -259853000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -510000000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -367400000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -145500000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -305300000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -145500000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

25.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 19163000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 9809000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 24807000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 19163000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5930000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 10264000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5930000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-581 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -367400000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -259853000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -510000000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -367400000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -145500000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -305300000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -145500000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 19163000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 9809000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 24807000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 19163000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5930000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 10264000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5930000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 7 of 11 periods available· newest 2024-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+376.6%

Prior period

USD 18.47 million

2024-01-01 – 2024-12-31
Current period

USD 88.04 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

88039000 − 18474000 = 69565000 USD

18474000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
88039000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Year-over-year change in Revenue: 69565000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 88039000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#1671840 Filing: 000119312526076495 Input fundies:Revenue: 18474000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#1673626 Filing: 000119312526076495
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 195.47 million

Prior period

−USD 589.53 million

2024-01-01 – 2024-12-31
Current period

−USD 785 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-785000000 − -589526000 = -195474000 USD

-589526000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-785000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Year-over-year change in Net income: -195474000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -785000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2423068 Filing: 000119312526076495 Input fundies:NetIncome: -589526000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2018309 Filing: 000119312526076495
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 114.11 million

Prior period

−USD 395.89 million

2024-01-01 – 2024-12-31
Current period

−USD 510 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-510000000 − -395890000 = -114110000 USD

-395890000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-510000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Year-over-year change in Operating cash flow: -114110000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -510000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2423914 Filing: 000119312526076495 Input fundies:OperatingCashFlow: -395890000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2256324 Filing: 000119312526076495
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+535.1%

Prior period

USD 3.91 million

2024-01-01 – 2024-12-31
Current period

USD 24.81 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

24807000 − 3906000 = 20901000 USD

3906000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
24807000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Year-over-year change in Capital expenditure: 20901000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 24807000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2286641 Filing: 000119312526076495 Input fundies:CapitalExpenditure: 3906000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2288550 Filing: 000119312526076495
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 88.04 million 100% of revenue
Operating costs Derived USD 700.3 million 795% of revenue
Operating income −USD 612.26 million −695% of revenue
Tax, interest and other Derived USD 172.74 million 196% of revenue
Net income −USD 785 million −892% of revenue

Cash

Operating cash flow −USD 510 million −579% of revenue
Capital expenditure USD 24.81 million 28% of revenue
Free cash flow Derived −USD 534.81 million −607% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 15%82%
2017 Operating loss: operating costs were 948% of revenue.
2018 Operating loss: operating costs were 382% of revenue.
2019 Operating loss: operating costs were 468% of revenue.
2020 Operating loss: operating costs were 268% of revenue.
2021 Operating loss: operating costs were 365% of revenue.
2022 Operating loss: operating costs were 443% of revenue.
2023 Operating loss: operating costs were 6,690% of revenue.
2024 Operating loss: operating costs were 3,003% of revenue.
2025 Operating loss: operating costs were 795% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	106407000	87720000 Derived	18687000	2234000 Derived	16453000	35386000 Derived	Source 2016-01-01 – 2016-12-31: 106407000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 18687000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 16453000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 36982000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 1596000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	13368000	126764000 Derived	-113396000	14394000 Derived	-127790000	-104636000 Derived	Source 2017-01-01 – 2017-12-31: 13368000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -113396000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -127790000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -101759000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 2877000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	31501000	120417000 Derived	-88916000	17373000 Derived	-106289000	-102104000 Derived	Source 2018-01-01 – 2018-12-31: 31501000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -88916000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -106289000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -101215000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 889000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	26868000	125735000 Derived	-98867000	22825000 Derived	-121692000	-93526000 Derived	Source 2019-01-01 – 2019-12-31: 26868000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -98867000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -121692000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -90907000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 2619000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	55828000	149771000 Derived	-93943000	33347000 Derived	-127290000	-2109000 Derived	Source 2020-01-01 – 2020-12-31: 55828000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -93943000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -127290000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 8943000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 11052000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	70428000	256741000 Derived	-186313000	29001000 Derived	-215314000	-191394000 Derived	Source 2021-01-01 – 2021-12-31: 70428000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -186313000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -215314000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -142522000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 48872000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	94588000	418790000 Derived	-324202000	64753000 Derived	-388955000	-310851000 Derived	Source 2022-01-01 – 2022-12-31: 94588000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -324202000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -388955000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -299516000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 11335000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	7530000	503735000 Derived	-496205000	30039000 Derived	-526244000	-415749000 Derived	Source 2023-01-01 – 2023-12-31: 7530000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -496205000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -526244000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -414333000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1416000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	18474000	554722000 Derived	-536248000	53278000 Derived	-589526000	-399796000 Derived	Source 2024-01-01 – 2024-12-31: 18474000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -536248000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -589526000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -395890000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 3906000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	88039000	700297000 Derived	-612258000	172742000 Derived	-785000000	-534807000 Derived	Source 2025-01-01 – 2025-12-31: 88039000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -612258000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -785000000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -510000000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 24807000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 88M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	106407000	Revenue: 106407000 Open source
20172017-12-31	Revenue	13368000	Revenue: 13368000 Open source
20182018-12-31	Revenue	31501000	Revenue: 31501000 Open source
20192019-12-31	Revenue	26868000	Revenue: 26868000 Open source
20202020-12-31	Revenue	55828000	Revenue: 55828000 Open source
20212021-12-31	Revenue	70428000	Revenue: 70428000 Open source
20222022-12-31	Revenue	94588000	Revenue: 94588000 Open source
20232023-12-31	Revenue	7530000	Revenue: 7530000 Open source
20242024-12-31	Revenue	18474000	Revenue: 18474000 Open source
20252025-12-31	Revenue	88039000	Revenue: 88039000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

376.6% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	271.3%	Revenue: 106407000 Open source Revenue: 28658000 Open source
20172017-12-31	Year over year	-87.4%	Revenue: 13368000 Open source Revenue: 106407000 Open source
20182018-12-31	Year over year	135.6%	Revenue: 31501000 Open source Revenue: 13368000 Open source
20192019-12-31	Year over year	-14.7%	Revenue: 26868000 Open source Revenue: 31501000 Open source
20202020-12-31	Year over year	107.8%	Revenue: 55828000 Open source Revenue: 26868000 Open source
20212021-12-31	Year over year	26.2%	Revenue: 70428000 Open source Revenue: 55828000 Open source
20222022-12-31	Year over year	34.3%	Revenue: 94588000 Open source Revenue: 70428000 Open source
20232023-12-31	Year over year	-92%	Revenue: 7530000 Open source Revenue: 94588000 Open source
20242024-12-31	Year over year	145.3%	Revenue: 18474000 Open source Revenue: 7530000 Open source
20252025-12-31	Year over year	376.6%	Revenue: 88039000 Open source Revenue: 18474000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -695.4% 2025

Net margin -891.7% 2025

Free cash flow margin -607.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	17.6%	Operating Income: 18687000 Open source Revenue: 106407000 Open source
20172017-12-31	Operating margin	-848.3%	Operating Income: -113396000 Open source Revenue: 13368000 Open source
20182018-12-31	Operating margin	-282.3%	Operating Income: -88916000 Open source Revenue: 31501000 Open source
20192019-12-31	Operating margin	-368%	Operating Income: -98867000 Open source Revenue: 26868000 Open source
20202020-12-31	Operating margin	-168.3%	Operating Income: -93943000 Open source Revenue: 55828000 Open source
20212021-12-31	Operating margin	-264.5%	Operating Income: -186313000 Open source Revenue: 70428000 Open source
20222022-12-31	Operating margin	-342.8%	Operating Income: -324202000 Open source Revenue: 94588000 Open source
20232023-12-31	Operating margin	-6,589.7%	Operating Income: -496205000 Open source Revenue: 7530000 Open source
20242024-12-31	Operating margin	-2,902.7%	Operating Income: -536248000 Open source Revenue: 18474000 Open source
20252025-12-31	Operating margin	-695.4%	Operating Income: -612258000 Open source Revenue: 88039000 Open source
20162016-12-31	Net margin	15.5%	Net Income: 16453000 Open source Revenue: 106407000 Open source
20172017-12-31	Net margin	-955.9%	Net Income: -127790000 Open source Revenue: 13368000 Open source
20182018-12-31	Net margin	-337.4%	Net Income: -106289000 Open source Revenue: 31501000 Open source
20192019-12-31	Net margin	-452.9%	Net Income: -121692000 Open source Revenue: 26868000 Open source
20202020-12-31	Net margin	-228%	Net Income: -127290000 Open source Revenue: 55828000 Open source
20212021-12-31	Net margin	-305.7%	Net Income: -215314000 Open source Revenue: 70428000 Open source
20222022-12-31	Net margin	-411.2%	Net Income: -388955000 Open source Revenue: 94588000 Open source
20232023-12-31	Net margin	-6,988.6%	Net Income: -526244000 Open source Revenue: 7530000 Open source
20242024-12-31	Net margin	-3,191.1%	Net Income: -589526000 Open source Revenue: 18474000 Open source
20252025-12-31	Net margin	-891.7%	Net Income: -785000000 Open source Revenue: 88039000 Open source
20162016-12-31	Free cash flow margin	33.3%	Revenue: 106407000 Open source Operating Cash Flow: 36982000 Open source Capital Expenditure: 1596000 Open source
20172017-12-31	Free cash flow margin	-782.7%	Revenue: 13368000 Open source Operating Cash Flow: -101759000 Open source Capital Expenditure: 2877000 Open source
20182018-12-31	Free cash flow margin	-324.1%	Revenue: 31501000 Open source Operating Cash Flow: -101215000 Open source Capital Expenditure: 889000 Open source
20192019-12-31	Free cash flow margin	-348.1%	Revenue: 26868000 Open source Operating Cash Flow: -90907000 Open source Capital Expenditure: 2619000 Open source
20202020-12-31	Free cash flow margin	-3.8%	Revenue: 55828000 Open source Operating Cash Flow: 8943000 Open source Capital Expenditure: 11052000 Open source
20212021-12-31	Free cash flow margin	-271.8%	Revenue: 70428000 Open source Operating Cash Flow: -142522000 Open source Capital Expenditure: 48872000 Open source
20222022-12-31	Free cash flow margin	-328.6%	Revenue: 94588000 Open source Operating Cash Flow: -299516000 Open source Capital Expenditure: 11335000 Open source
20232023-12-31	Free cash flow margin	-5,521.2%	Revenue: 7530000 Open source Operating Cash Flow: -414333000 Open source Capital Expenditure: 1416000 Open source
20242024-12-31	Free cash flow margin	-2,164.1%	Revenue: 18474000 Open source Operating Cash Flow: -395890000 Open source Capital Expenditure: 3906000 Open source
20252025-12-31	Free cash flow margin	-607.5%	Revenue: 88039000 Open source Operating Cash Flow: -510000000 Open source Capital Expenditure: 24807000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -510M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	36982000	Operating Cash Flow: 36982000 Open source
20172017-12-31	Operating cash flow	-101759000	Operating Cash Flow: -101759000 Open source
20182018-12-31	Operating cash flow	-101215000	Operating Cash Flow: -101215000 Open source
20192019-12-31	Operating cash flow	-90907000	Operating Cash Flow: -90907000 Open source
20202020-12-31	Operating cash flow	8943000	Operating Cash Flow: 8943000 Open source
20212021-12-31	Operating cash flow	-142522000	Operating Cash Flow: -142522000 Open source
20222022-12-31	Operating cash flow	-299516000	Operating Cash Flow: -299516000 Open source
20232023-12-31	Operating cash flow	-414333000	Operating Cash Flow: -414333000 Open source
20242024-12-31	Operating cash flow	-395890000	Operating Cash Flow: -395890000 Open source
20252025-12-31	Operating cash flow	-510000000	Operating Cash Flow: -510000000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -534.8M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	35386000	Operating Cash Flow: 36982000 Open source Capital Expenditure: 1596000 Open source
20172017-12-31	Free cash flow	-104636000	Operating Cash Flow: -101759000 Open source Capital Expenditure: 2877000 Open source
20182018-12-31	Free cash flow	-102104000	Operating Cash Flow: -101215000 Open source Capital Expenditure: 889000 Open source
20192019-12-31	Free cash flow	-93526000	Operating Cash Flow: -90907000 Open source Capital Expenditure: 2619000 Open source
20202020-12-31	Free cash flow	-2109000	Operating Cash Flow: 8943000 Open source Capital Expenditure: 11052000 Open source
20212021-12-31	Free cash flow	-191394000	Operating Cash Flow: -142522000 Open source Capital Expenditure: 48872000 Open source
20222022-12-31	Free cash flow	-310851000	Operating Cash Flow: -299516000 Open source Capital Expenditure: 11335000 Open source
20232023-12-31	Free cash flow	-415749000	Operating Cash Flow: -414333000 Open source Capital Expenditure: 1416000 Open source
20242024-12-31	Free cash flow	-399796000	Operating Cash Flow: -395890000 Open source Capital Expenditure: 3906000 Open source
20252025-12-31	Free cash flow	-534807000	Operating Cash Flow: -510000000 Open source Capital Expenditure: 24807000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

146.3% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	44.5%	Total Liabilities: 75781000 Open source Total Assets: 170142000 Open source
20172017-12-31	Liabilities / assets	62.7%	Total Liabilities: 184968000 Open source Total Assets: 294810000 Open source
20182018-12-31	Liabilities / assets	87.7%	Total Liabilities: 185244000 Open source Total Assets: 211178000 Open source
20192019-12-31	Liabilities / assets	103.8%	Total Liabilities: 300751000 Open source Total Assets: 289814000 Open source
20202020-12-31	Liabilities / assets	78.8%	Total Liabilities: 420420000 Open source Total Assets: 533803000 Open source
20212021-12-31	Liabilities / assets	71%	Total Liabilities: 597456000 Open source Total Assets: 841319000 Open source
20222022-12-31	Liabilities / assets	110.6%	Total Liabilities: 1122675000 Open source Total Assets: 1014775000 Open source
20232023-12-31	Liabilities / assets	146.9%	Total Liabilities: 1210639000 Open source Total Assets: 824316000 Open source
20242024-12-31	Liabilities / assets	109.7%	Total Liabilities: 1537045000 Open source Total Assets: 1401673000 Open source
20252025-12-31	Liabilities / assets	146.3%	Total Liabilities: 2084162000 Open source Total Assets: 1424537000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.53× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	4.77×	Current Assets: 158633000 Open source Current Liabilities: 33258000 Open source
20172017-12-31	Current assets / current liabilities	8.45×	Current Assets: 274295000 Open source Current Liabilities: 32444000 Open source
20182018-12-31	Current assets / current liabilities	9.36×	Current Assets: 207674000 Open source Current Liabilities: 22194000 Open source
20192019-12-31	Current assets / current liabilities	8.98×	Current Assets: 233752000 Open source Current Liabilities: 26023000 Open source
20202020-12-31	Current assets / current liabilities	15.2×	Current Assets: 474221000 Open source Current Liabilities: 31199000 Open source
20212021-12-31	Current assets / current liabilities	7.45×	Current Assets: 535672000 Open source Current Liabilities: 71860000 Open source
20222022-12-31	Current assets / current liabilities	9.4×	Current Assets: 795186000 Open source Current Liabilities: 84617000 Open source
20232023-12-31	Current assets / current liabilities	6.12×	Current Assets: 628051000 Open source Current Liabilities: 102678000 Open source
20242024-12-31	Current assets / current liabilities	6.17×	Current Assets: 1107940000 Open source Current Liabilities: 179674000 Open source
20252025-12-31	Current assets / current liabilities	4.53×	Current Assets: 916975000 Open source Current Liabilities: 202452000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	USD 16.45 million Exact value Exact value: 16453000 USD 2016-01-01 – 2016-12-31: 16453000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2016-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: 16453000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 16453000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459018004398/cytk-20171231.xml#176612 Filing: 000156459018004398 The citation records this snapshot. The page link may show a newer release later.	USD 36.98 million Exact value Exact value: 36982000 USD 2016-01-01 – 2016-12-31: 36982000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2016-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: 36982000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 36982000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459018004398/cytk-20171231.xml#213111 Filing: 000156459018004398 The citation records this snapshot. The page link may show a newer release later.	USD 1.6 million Exact value Exact value: 1596000 USD 2016-01-01 – 2016-12-31: 1596000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2016-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 1596000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1596000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459018004398/cytk-20171231.xml#215201 Filing: 000156459018004398 The citation records this snapshot. The page link may show a newer release later.	USD 35.39 million Calculation and evidence 36982000 − 1596000 USD Exact free cash flow: 35386000 USD 2016-01-01 – 2016-12-31: 36982000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 1596000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2016-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: 35386000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 36982000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459018004398/cytk-20171231.xml#213111 Filing: 000156459018004398 Input fundies:CapitalExpenditure: 1596000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459018004398/cytk-20171231.xml#215201 Filing: 000156459018004398 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 127.79 million Exact value Exact value: -127790000 USD 2017-01-01 – 2017-12-31: -127790000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2017-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -127790000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -127790000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459019006580/cytk-20181231.xml#164454 Filing: 000156459019006580 The citation records this snapshot. The page link may show a newer release later.	−USD 101.76 million Exact value Exact value: -101759000 USD 2017-01-01 – 2017-12-31: -101759000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2017-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -101759000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -101759000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459019006580/cytk-20181231.xml#203995 Filing: 000156459019006580 The citation records this snapshot. The page link may show a newer release later.	USD 2.88 million Exact value Exact value: 2877000 USD 2017-01-01 – 2017-12-31: 2877000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2017-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 2877000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2877000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459019006580/cytk-20181231.xml#205337 Filing: 000156459019006580 The citation records this snapshot. The page link may show a newer release later.	−USD 104.64 million Calculation and evidence -101759000 − 2877000 USD Exact free cash flow: -104636000 USD 2017-01-01 – 2017-12-31: -101759000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2877000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2017-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -104636000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -101759000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459019006580/cytk-20181231.xml#203995 Filing: 000156459019006580 Input fundies:CapitalExpenditure: 2877000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459019006580/cytk-20181231.xml#205337 Filing: 000156459019006580 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 106.29 million Exact value Exact value: -106289000 USD 2018-01-01 – 2018-12-31: -106289000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2018-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -106289000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -106289000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459021009467/cytk-10k_20201231.htm#1875563 Filing: 000156459021009467 The citation records this snapshot. The page link may show a newer release later.	−USD 101.22 million Exact value Exact value: -101215000 USD 2018-01-01 – 2018-12-31: -101215000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2018-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -101215000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -101215000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459021009467/cytk-10k_20201231.htm#2268195 Filing: 000156459021009467 The citation records this snapshot. The page link may show a newer release later.	USD 889,000 Exact value Exact value: 889000 USD 2018-01-01 – 2018-12-31: 889000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2018-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 889000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 889000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459021009467/cytk-10k_20201231.htm#2296772 Filing: 000156459021009467 The citation records this snapshot. The page link may show a newer release later.	−USD 102.1 million Calculation and evidence -101215000 − 889000 USD Exact free cash flow: -102104000 USD 2018-01-01 – 2018-12-31: -101215000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 889000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2018-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -102104000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -101215000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459021009467/cytk-10k_20201231.htm#2268195 Filing: 000156459021009467 Input fundies:CapitalExpenditure: 889000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459021009467/cytk-10k_20201231.htm#2296772 Filing: 000156459021009467 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 121.69 million Exact value Exact value: -121692000 USD 2019-01-01 – 2019-12-31: -121692000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2019-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -121692000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -121692000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459022007218/cytk-10k_20211231.htm#1985017 Filing: 000156459022007218 The citation records this snapshot. The page link may show a newer release later.	−USD 90.91 million Exact value Exact value: -90907000 USD 2019-01-01 – 2019-12-31: -90907000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2019-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -90907000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -90907000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459022007218/cytk-10k_20211231.htm#2373344 Filing: 000156459022007218 The citation records this snapshot. The page link may show a newer release later.	USD 2.62 million Exact value Exact value: 2619000 USD 2019-01-01 – 2019-12-31: 2619000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2019-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 2619000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2619000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459022007218/cytk-10k_20211231.htm#2402291 Filing: 000156459022007218 The citation records this snapshot. The page link may show a newer release later.	−USD 93.53 million Calculation and evidence -90907000 − 2619000 USD Exact free cash flow: -93526000 USD 2019-01-01 – 2019-12-31: -90907000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 2619000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2019-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -93526000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -90907000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459022007218/cytk-10k_20211231.htm#2373344 Filing: 000156459022007218 Input fundies:CapitalExpenditure: 2619000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000156459022007218/cytk-10k_20211231.htm#2402291 Filing: 000156459022007218 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 127.29 million Exact value Exact value: -127290000 USD 2020-01-01 – 2020-12-31: -127290000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2020-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -127290000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -127290000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/cytk-20221231.htm#2282049 Filing: 000095017023005515 The citation records this snapshot. The page link may show a newer release later.	USD 8.94 million Exact value Exact value: 8943000 USD 2020-01-01 – 2020-12-31: 8943000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2020-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: 8943000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8943000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/cytk-20221231.htm#2706932 Filing: 000095017023005515 The citation records this snapshot. The page link may show a newer release later.	USD 11.05 million Exact value Exact value: 11052000 USD 2020-01-01 – 2020-12-31: 11052000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2020-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 11052000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11052000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/cytk-20221231.htm#2738468 Filing: 000095017023005515 The citation records this snapshot. The page link may show a newer release later.	−USD 2.11 million Calculation and evidence 8943000 − 11052000 USD Exact free cash flow: -2109000 USD 2020-01-01 – 2020-12-31: 8943000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 11052000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2020-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -2109000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8943000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/cytk-20221231.htm#2706932 Filing: 000095017023005515 Input fundies:CapitalExpenditure: 11052000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017023005515/cytk-20221231.htm#2738468 Filing: 000095017023005515 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 215.31 million Exact value Exact value: -215314000 USD 2021-01-01 – 2021-12-31: -215314000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2021-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -215314000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -215314000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/cytk-20231231.htm#1645392 Filing: 000095017024022256 The citation records this snapshot. The page link may show a newer release later.	−USD 142.52 million Exact value Exact value: -142522000 USD 2021-01-01 – 2021-12-31: -142522000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2021-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -142522000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -142522000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/cytk-20231231.htm#1905468 Filing: 000095017024022256 The citation records this snapshot. The page link may show a newer release later.	USD 48.87 million Exact value Exact value: 48872000 USD 2021-01-01 – 2021-12-31: 48872000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2021-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 48872000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48872000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/cytk-20231231.htm#1925175 Filing: 000095017024022256 The citation records this snapshot. The page link may show a newer release later.	−USD 191.39 million Calculation and evidence -142522000 − 48872000 USD Exact free cash flow: -191394000 USD 2021-01-01 – 2021-12-31: -142522000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 48872000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2021-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -191394000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -142522000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/cytk-20231231.htm#1905468 Filing: 000095017024022256 Input fundies:CapitalExpenditure: 48872000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017024022256/cytk-20231231.htm#1925175 Filing: 000095017024022256 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 388.96 million Exact value Exact value: -388955000 USD 2022-01-01 – 2022-12-31: -388955000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2022-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -388955000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -388955000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/cytk-20241231.htm#1652053 Filing: 000095017025029206 The citation records this snapshot. The page link may show a newer release later.	−USD 299.52 million Exact value Exact value: -299516000 USD 2022-01-01 – 2022-12-31: -299516000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2022-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -299516000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -299516000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/cytk-20241231.htm#2000022 Filing: 000095017025029206 The citation records this snapshot. The page link may show a newer release later.	USD 11.34 million Exact value Exact value: 11335000 USD 2022-01-01 – 2022-12-31: 11335000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2022-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 11335000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11335000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/cytk-20241231.htm#2024817 Filing: 000095017025029206 The citation records this snapshot. The page link may show a newer release later.	−USD 310.85 million Calculation and evidence -299516000 − 11335000 USD Exact free cash flow: -310851000 USD 2022-01-01 – 2022-12-31: -299516000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 11335000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2022-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -310851000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -299516000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/cytk-20241231.htm#2000022 Filing: 000095017025029206 Input fundies:CapitalExpenditure: 11335000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000095017025029206/cytk-20241231.htm#2024817 Filing: 000095017025029206 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 526.24 million Exact value Exact value: -526244000 USD 2023-01-01 – 2023-12-31: -526244000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2023-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -526244000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -526244000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#1888666 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	−USD 414.33 million Exact value Exact value: -414333000 USD 2023-01-01 – 2023-12-31: -414333000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2023-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -414333000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -414333000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2258243 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	USD 1.42 million Exact value Exact value: 1416000 USD 2023-01-01 – 2023-12-31: 1416000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2023-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 1416000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1416000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2290458 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	−USD 415.75 million Calculation and evidence -414333000 − 1416000 USD Exact free cash flow: -415749000 USD 2023-01-01 – 2023-12-31: -414333000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1416000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2023-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -415749000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -414333000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2258243 Filing: 000119312526076495 Input fundies:CapitalExpenditure: 1416000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2290458 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 589.53 million Exact value Exact value: -589526000 USD 2024-01-01 – 2024-12-31: -589526000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2024-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -589526000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -589526000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2018309 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	−USD 395.89 million Exact value Exact value: -395890000 USD 2024-01-01 – 2024-12-31: -395890000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2024-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -395890000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -395890000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2256324 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	USD 3.91 million Exact value Exact value: 3906000 USD 2024-01-01 – 2024-12-31: 3906000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2024-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 3906000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3906000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2288550 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	−USD 399.8 million Calculation and evidence -395890000 − 3906000 USD Exact free cash flow: -399796000 USD 2024-01-01 – 2024-12-31: -395890000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 3906000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2024-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -399796000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -395890000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2256324 Filing: 000119312526076495 Input fundies:CapitalExpenditure: 3906000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2288550 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 785 million Exact value Exact value: -785000000 USD 2025-01-01 – 2025-12-31: -785000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Net Income: -785000000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -785000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2423068 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	−USD 510 million Exact value Exact value: -510000000 USD 2025-01-01 – 2025-12-31: -510000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Operating Cash Flow: -510000000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -510000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2423914 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	USD 24.81 million Exact value Exact value: 24807000 USD 2025-01-01 – 2025-12-31: 24807000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Capital Expenditure: 24807000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 24807000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2286641 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.	−USD 534.81 million Calculation and evidence -510000000 − 24807000 USD Exact free cash flow: -534807000 USD 2025-01-01 – 2025-12-31: -510000000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 24807000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOKINETICS INC · 2025-12-31 CYTOKINETICS INC (edgar:1061983) Free cash flow: -534807000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1061983?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -510000000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2423914 Filing: 000119312526076495 Input fundies:CapitalExpenditure: 24807000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/cytk-20251231.htm#2286641 Filing: 000119312526076495 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

194 filings · 4,617 latest values · 4,617 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001061983, 1061983, CYTK, edgar:1061983

Also known as CYTOKINETICS INC, CYTOKINETICS, INCORPORATED, Cytokinetics, Incorporated

CYTOKINETICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation